GlassScriptPhysician profile
Allison D Rice
NPI 1730610809
$4,097.04
in general payments reported to CMS, 2019-2025
14 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,316 · 2022: $16.40 · 2023: $1,937 · 2024: $452 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394 · Travel and Lodging: $1,354 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,393.83 |
| Travel and Lodging | $1,354.21 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,667.01 | 2023 | Da Vinci Surgical System |
| Allergan, INC. | $1,200.23 | 2019 | |
| Medtronic, INC. | $306.52 | 2023-2024 | Reliatack |
| Novo Nordisk INC | $259.67 | 2024-2025 | Wegovy |
| Innovation Technologies INC | $188.15 | 2024 | Irrisept |
| Abbott Laboratories | $103.67 | 2024 | Esprit |
| Merck Sharp & Dohme LLC | $97.22 | 2019 | |
| Abbvie INC. | $62.32 | 2022-2025 | |
| Intra-Sana Laboratories | $51.86 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Currax Pharmaceuticals LLC | $50.42 | 2025 | Contrave |
| Integra Lifesciences Corporation | $45.02 | 2024 | Integra, Omnigraft, Surgimend |
| Tela Bio, INC. | $28.55 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Shire North American Group INC | $18.90 | 2019 | |
| Vivus LLC | $17.50 | 2024 | Pancreaze |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.